Risk factor
Poor trading liquidity
Profitability factor
Very low or no dividends
About
Stille AB is a Swedish-headquartered company, operating globally, that specializes in the design, manufacture, and sale of surgical instruments. Their extensive portfolio of medical tools encompasses a wide variety of items such as specialized forceps (including artery, ligature, wire twisting, and general types), bone-cutting instruments like cutters and rongeurs, various clamps, curettes, raspatories, elevators, needle holders, micro instruments, osteotomes, chisels, retractors, skin hooks, and scissors. Additionally, they provide C-arm tables. These products are essential for a broad range of surgical disciplines, including ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries, as well as general open surgical procedures. Beyond product provision, Stille also offers crucial post-sales support services, such as instrument repair, routine maintenance, and thorough inspections. The company leverages strategic partnerships, notably a collaboration agreement with GE Healthcare and a distribution arrangement with Synovis Micro. Its sales strategy involves direct customer engagement, distribution networks, and supply to OEM manufacturers of C-frame systems. Founded in 1841 and headquartered in Torshälla, Sweden, Stille AB operates as a subsidiary of Linc AB.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI
Target Price
The average target price of STIL.ST is 285 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation